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Abstract  
BACKGROUND: Recently epidemiological studies showed that low vitamin D is linked to airway 
hyperresponsiveness, decreased lung function, poor asthma control, and steroid–resistant asthma. 
AIM: We investigated the relationship between Vitamin D, inflammation with circulating IL-33 and lung function in 
30 patients with severe uncontrolled asthma. 
MATERIALS AND METHODS: The study included 30 patients with severe uncontrolled asthma. In each of them 
were measured serum levels of IL-33 and Vitamin D by the ELISA method. The pulmonary function is measured 
by basic spirometry parameters, FEV1. The results were statistically elaborated according to the Pearson’s 
Correlation Tests. 
RESULTS: The results showed statistically insignificant correlation between Vitamin D and IL-33, and Vitamin D 
with FEV1 (Vit.D/IL-33; r = 0.11323, p = 0.551); (Vit.D/FEV1; r = -0.1005; p = 0.597) Correlation between IL-33 
and FEV1 is negative but statistically significant (IL-33/FEV1; r = -0.5248; p = 0.003). 
CONCLUSION: Because there are little studies about the link between vitamin D and asthma, further research to 
clarify the mechanism how vitamin D control the activity of CD4+ T cells and the related Th2-type cytokines in the 
parthenogenesis of asthma. 
 
 
 
 
Introduction 
 
Asthma is the leading chronic respiratory 
diseases which affect more than 334 million people 
worldwide [1-3]. It is estimated that the number of 
people with asthma will grow by more than 100 million 
by 2025. Women were more likely than men and boys 
more likely than girls to have asthma [4]. 
Approximately 500,000 annual hospitalisations are 
due to asthma, and 250 000 deaths annually [3]. Five 
percentages or 100,000 of the 
Macedonian population have asthma [5, 6]. 
 Characteristic mechanisms of asthma include 
inflammation, hyperresponsiveness and structural 
changes in the airways and the lung. Many cellular 
elements and different cells play a role (T 
lymphocytes, neutrophils, eosinophils, mast cells, 
macrophages, and dendritic cells). Recurrent 
episodes of wheezing, chest tightness, coughing and 
breathlessness, particularly at night or in the early 
morning are a clinical expression of this disease. 
These episodes are usually variable, and the airflow 
obstruction within the lung is often reversible with 
treatment or spontaneously [7]. 
 Chronic inflammation of the asthmatic airway 
leads to epithelial desquamation, infiltration of the 
airway wall with T cells especially dominated Th2 
helper CD4+ lymphocytes, smooth muscle, 
hypertrophy and hyperplasia, vascular congestion, 
oedema due to plasma leakage and mucus plugging 
[8-11]. All these changes could lead to thickening of 
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the airway walls due to subepithelial fibrosis and 
reduction of their lumen [12, 13]. 
  More than 100 mediators and markers of 
inflammation are involved in this inflammation. 
Cytokines take place in complex pathophysiological 
process, and they are produced by cells like T cells, 
Tc, Th, Th1, Th2, NK, dendritic cells, B cells, 
endothelial cells, plasma cells, mast cells, bone 
marrow, tumor cells and thymus, together with, 
leukocytes, macrophages, fibroblasts, and monocytes 
[14, 15]. The interleukins are cytokines which can 
stimulate the proliferation and differentiation of 
immune cells. In asthma, T cells take a central place 
in coordinating the immune response. Cytokines 
present during activation of naïve CD4 + T cells from 
pathogens and many types of antigens differentiate 
them into subpopulations of T cells in T-follicular 
effector cells, Th1, Th2, Th9, Th17, and Th22. Th2 
cells synthesise IL-4, IL-5, IL-13, IL-25, IL-31, IL-33 
which are associated with asthma and allergic 
diseases [16-19]. 
Interleukin 33 (IL-33) is a new cytokine which 
was found in 2005. It belongs to the IL-1 family 
consisting of 11 members, high proinflammatory 
cytokines which activate the function of inflammation 
cell in the early asthmatic responses. IL-33 is a potent 
type 2 inducing cytokine. It is bind to ST2 receptors, 
which are expressed on mast cells and Th2 cells, and 
some various cells including epithelial, bronchial and 
endothelial cells, fibroblasts and some immune cells, 
as well as dendritic cells and macrophages [20-23]. It 
is assumed that IL-33 is one of the earliest released 
mediators and can orchestrate the immune cascade 
of asthma and stands out as an attractive candidate 
for discovering various therapeutic modalities, 
especially a new targeted therapy. 
 Vitamin D plays a role in the pathogenesis of 
asthma. Vitamin D is a potent immune system 
modulator and in the form of 1,25-dihydroxy vitamin D 
has been shown that it can be involved in the 
suppression of dendritic cell maturation and the 
development of consecutive Th1 cell [24-27]. Vitamin 
D may suppress the production of IL-12, which 
reduces the production of Th1 cells and potentially 
leading to increased proliferation of Th2 cells [25]. 
Additionally, studies with treatment of 1,25-dihydroxy 
vitamin D in mice showed reduced secretion of Th1-
type cytokines IL-2 and IFN-γ and an increase in Th2-
type IL-4. In asthmatic children, low vitamin D levels 
are associated with airway hyperresponsiveness, 
decreased lung function, worse asthma control, and 
steroid-resistant asthma and exacerbations. It remains 
unknown whether vitamin D is an association with 
increased airway hyperresponsiveness (AWH), 
inflammatory markers of asthma, decreased lung 
function, poor asthma control and steroid resistance in 
adult asthma patients [28-30]. 
We aimed to investigate the relationship 
between Vitamin D, inflammation with circulating IL-33 
and lung function in 30 patients with severe 
uncontrolled asthma. 
 
 
Material and Methods 
 
The study included 30 patients with asthma. 
They are diagnosis and treated at the Clinic of 
Pulmonology and Allergy in Skopje, Macedonia. All of 
them are a classification of uncontrolled moderate 
persistent asthma. In all patients, serum IL-33 level 
was measured by the ELISA, enzyme-linked 
immunosorbent assay method according to the 
manufacture’s protocol at the Institute of 
Immunobiology and Human Genetics, Faculty of 
Medicine, in Skopje, Macedonia. Values within the 
reference range for IL-33 are 0pg/ml. Serum 25-
hydroxyvitamin D was measured by ELISA method 
according to the manufacture’s protocol at University 
Clinic of Clinical biochemist, Skopje, Macedonia.  
At the Clinic of pulmonology and allergy in 
Skopje, was done the spirometry with turbine 
spirometer - Spirobank G, according to the standard 
methodology. In all patients was done and analysed 
FEV1 - Forced expiratory volume in the first second. 
Every patient is done three manoeuvres with three 
acceptable and three reproducible curves, according 
to guidelines for the measurement of Spirometry, with 
Flow‐Volume and Time‐Volume curve. The best curve 
has been automatically selected from the spirometer 
[31-33]. 
 Inclusion Criteria: the patients are diagnosed 
and classified in uncontrolled moderate persistent 
asthma at PHI University Clinic of Pulmonology and 
Allergy according to the actual version of the Global 
Initiative for Asthma guidelines – GINA [7] and 
Guidelines for the Diagnosis and Management of 
Asthma (EPR-3) of NAEPP, National Asthma 
Education Prevention Program [33].
 
Uncontrolled 
asthma defined as at least one of the following [34]. 
Poor asthma symptom control: Asthma 
Control Questionnaire (ACQ) consistently >1.5, or 
Asthma Control Test <20 (or ‘‘not well controlled’’ by 
GINA - NAEPP guidelines over three months of 
evaluation: 
 two or more bursts of systemic CS (3 days 
each) in the previous year - frequent severe 
exacerbations; 
 at least one hospitalisation, required to stay 
on ICU or mechanical ventilation in the 
previous year - serious exacerbations; and 
 after an appropriate bronchodilator withhold 
FEV1<80% predicted - airflow limitation. 
 All patients have stable asthma because there 
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has been no increase asthma symptoms or need for 
add another asthma medication for at least the past 
four weeks. Some of the patients have arterial 
hypertension, and they did not have other 
comorbidities, that could increase the IL-33 level. The 
age range of patients was 20-71 years old. 
  Exclusion criteria were severe diseases of 
renal, neurological, haematological, cardiac, 
gastrointestinal, endocrine or immune system, 
psychiatric disorders, and neoplastic diseases. 
Pregnancy is also exclusion criteria. 
 
Statistical analysis 
 The results were statistically analysed by the 
statistical program SPSS for Windows 17.0. The 
results were statistically analyzed according to the 
Pearson’s Correlation Tests. The significances values 
were taken p < 0.05. 
 
 
Results 
 
The study included 30 patients with severe 
uncontrolled asthma. The majority were females, 19 
women (63.33%), and 11 were men (36.67%). The 
age of the patients was 20-71 years. The obtained 
values showed (Table 1): 
Table 1: Mean values for Vitamin D, IL-33 and FEV1 
N-30 mean Std.Dv 
Vitamin D 15.260 5.808 
IL-33 33.461 8.851 
FEV1 44.367 14.207 
 
All patients had low serum vitamin D and their 
correlation with IL-33 showed statistically insignificant 
correlation (Vit.D/IL-33; r = 0.11323; p = 0.551) 
(Figure 1). 
Scatterplot: il-33 vs. vit d3 (Casewise MD deletion)
vit d3 = 14,940 + ,00955 * il-33
Correlation: r = ,11323
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Figure 1: Correlation between Vitamin D and IL-33 in asthma 
patients.  (r = -0.11323; p = 0.551) 
Negative significant correlation between IL-33 
and FEV1 (IL-33/FEV1; r = -0.5248; p = 0.003) (Figure 
2). 
Scatterplot: il-33 vs. fev1 (Casewise MD deletion)
fev1 = 47,990 - ,1083  * il-33
Correlation: r = -,5248
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Figure 2: Correlation between IL-33 and FEV1 in asthma patients. (r 
= -0.5248; p = 0.003) 
 
Negative insignificant correlation between 
serum levels of vitamin D and FEV1 (Vit.D/ FEV1; r =  
-0.1005; p = 0.597) (Figure 3) 
Scatterplot: vit d3 vs. fev1 (Casewise MD deletion)
fev1 = 48,119 - ,2459  * vit d3
Correlation: r = -,1005
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Figure 3: Correlation between Vitamin D and FEV1 in asthma 
patients. (r= -0.1005; p = 0.597) 
 
 
Discussion 
 
The studies which investigate vitamin D 
status, inflammatory markers of asthma and lung 
function are scarce. The studies which investigated 
the direct mechanistic links between vitamin D and 
lung diseases are limited. Cross section of data 
indicate that low level of vitamin D in patients with mild 
and moderate asthma is associated with more 
frequent exacerbations, poor asthma control, 
decreased lung function, steroid–resistant asthma, 
and consequent increased steroid use [24-26, 35-37].
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A couple study presented that the low level of 
vitamin D has an association with airway obstruction 
and corticosteroid requirement, influencing the 
severity in asthmatic patients. Our study showed that 
serum vitamin D level was lower (level of vitamin D < 
30 ng/ml) in these 30 patients with asthma but their 
correlation with IL-33 was statistically insignificantly. 
Anna Bonanno et al. in their study showed that 
Vitamin D it is not involved in IL-33/IL-31, Th2-type 
cytokines activity implicated in bronchial and nasal 
allergic disease [24].
 
Felicia M.A. et al. in their study 
they did not find a link between allergy markers 
(allergic rhinitis, eosinophil count, total IgE) and 
vitamin D levels [38].
 
Vitamin D inhibits the synthesis and releases 
cytokines which are Th1-associated and some other 
molecules, like IL-17, which lead to decreased 
inflammation and proliferation of smooth muscle cell 
[35, 38, 39]. Recent studies have shown that low level 
of vitamin D is linked with increased expression of the 
pro-inflammatory cytokine TNF-α, enhancing a pro-
inflammatory effect in patients with asthma [35, 40]. 
This vitamin promotes regulatory T cells and also in-
creases synthesis of IL-10, which lead to an inhibition 
of Th2 responses as well as airway inflammation and 
airway hyperresponsiveness [35, 41]. 
 Larose et al. in HUNT, prospective cohort 
study, found that low serum 25(OH) D level was not 
correlated with airway obstruction in most asthmatics 
adults except men with asthma but without allergic 
rhinitis [42]. In our study, there was an insignificant 
correlation between serum levels of vitamin D and 
FEV1. Laura et al. also showed in their study that the 
vitamin D level did not correlate with lung function and 
markers of allergy in asthmatic patients [43].
 
Some 
studies show a significant direct relation between 
vitamin D level and both FEV1 and FEV1/FVC [43, 
44].
 
In this study, we found that serum IL-33 was 
increased in patients with asthma and they positively 
correlated with asthma severity with the significant 
negative correlation between IL-33 and FEV1. In 
human studies of allergic asthma, serum IL-33, 
bronchoalveolar lavage fluid and lung tissue have 
found to be higher in patients with asthma compared 
to healthy controls and correlate with asthma severity 
[45-50], which was confirmed in our study
 
In conclusion, despite the limitation of this 
study with a small number of patients, we found an 
increased serum IL-33 in patients with asthma and it 
is positively related to the severity of asthma (FEV1), 
but we did not find a correlation between levels of 
vitamin D and FEV1 and IL-33. Because there are 
little studies about the link between asthma and 
vitamin D, further studies are necessary to explain the 
mechanism how vitamin D can control the activity of 
CD4+ T cells and the related Th2 type cytokines in the 
pathogenesis of the allergic disease, including 
asthma. 
References 
1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of 
asthma: executive summary of the GINA Dissemination 
Committee report. Allergy. 2004; 59(5): 469-478. 
https://doi.org/10.1111/j.1398-9995.2004.00526.x PMid:15080825  
2. Beasley R. The Global Burden of Asthma Report, Global 
Initiative for Asthma (GINA). Available from 
http://www.ginasthma.org 2004. 
 
3. World Health Organization. Global surveillance, prevention and 
control of chronic respiratory diseases: a comprehensive 
approach, 2007. 
 
4. Centers for Disease Control and Prevention, Vital Signs, May 
2011.  
5. Gjorcev A. Makedonski nacionalen plan i program za dijag-
nostikai lekuvanje na bronhilajnata asthma-realnost i vizija, 1996.  
6. Vladimir Cvetanov. Alergiskite bolesti vo R. Makedonija, 2006: 
151-174.  
7. Global Initiative for Asthma (GINA), GINA Report 2017, Global 
Strategy for Asthma Management and Prevention updated 2017. 
http://www.ginasthma.org 
 
8. Holgate ST. Genetic and environmental interaction in Allergy 
and asthma. J Allergy Clin Immunol. 1999; 104(6): 1139-1146. 
https://doi.org/10.1016/S0091-6749(99)70005-9 
 
9. Thomas MJ, Kemeny DM. Novel CD4 and CDS T-cell subsets. 
Allergy. 1998; 53: 1122-1132. https://doi.org/10.1111/j.1398-
9995.1998.tb03831.x 
 
10. Heard BE, Hossain S. Hyperplasia of bronchial muscle in 
asthma. J Pathol. 1973; 110: 319-331. 
https://doi.org/10.1002/path.1711100406 
 
11. Shiels IA, Bowler SD, Taylor SM. Airway smooth muscle 
proliferation in asthma: the potential of vascular leakage to 
contribute to pathogenesis. Med Hypotheses. 1995; 45: 37-40. 
https://doi.org/10.1016/0306-9877(95)90198-1 
 
12. Dirkje S Postma, Wim Timens. Remodeling in Asthma and 
Chronic Obstructive Pulmonary Disease. American Thoracic 
Society. 2006; 3(5): 434-439. https://doi.org/10.1513/pats.200601-
006AW PMid:16799088  
 
13. Christopher L. Grainge, Laurie C.K. Lau, Jonathon A. Ward, et 
al. Effect of bronchoconstriction on Airway Remodeling in Asthma. 
N Engl J Med. 2011; 364: 2006-2015. 
https://doi.org/10.1056/NEJMoa1014350 PMid:21612469  
 
14. Barnes PJ. Pathophysiology of asthma. Eur Respir Mon. 2003; 
23: 84-113.  
15. Kuipers H, Lambrecht BN. The interplay of dendritic cells, 
Th2cells and regulatory T cells in asthma. Curr Opin Immunol. 
2004; 16(6): 702-708. https://doi.org/10.1016/j.coi.2004.09.010 
PMid:15511661  
 
16. Abbas AK, Lichtman Ah, Pober JS. Cellular and Molecular 
Immunology. 4th ed., 2000: 235-69.  
17. Roitt IM, and Delves PJ. Essential Immunology, 10th ed., 
2001: 177-199.  
18. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in 
the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111: 
450-463. https://doi.org/10.1067/mai.2003.169 PMid:12642820  
 
19. Zhu J, Hidehiro Y, William EP. Differentiation of effector CD4 T 
cell populations. Annu Rev Immunol. 2010;28: 445-489. 
https://doi.org/10.1146/annurev-immunol-030409-101212 
PMid:20192806 PMCid:PMC3502616 
 
20. Borish L, Steinke JW. Interleukin-33 in asthma: how big of a 
role does it play? Curr Allergy Asthma Rep. 2011; 11: 7-11. 
https://doi.org/10.1007/s11882-010-0153-8 PMid:20931364 
PMCid:PMC3068600 
 
21. Schmitz J, Owyang A, Oldham E., et al. et al. IL-33, an 
interleukin-1-like cytokine that signals via the IL-1 receptor-related 
protein ST2 and induces T-helper type 2-associated cytokines. 
 
Janeva-Jovanovska et al. Vitamin D, Inflammation and Lung Function In Patients with Severe Uncontrolled Asthma 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Dec 15; 5(7):899-903.                                                                                                                                                        903 
Immunity. 2005; 23: 479-490. 
https://doi.org/10.1016/j.immuni.2005.09.015 PMid:16286016  
22. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target 
and novel biomarker. Nat Rev Drug Discov 2008; 7: 827-840. 
https://doi.org/10.1038/nrd2660 PMid:18827826 
PMCid:PMC4277436 
 
23. Miller AM. Role of IL-33 in inflammation and disease. J 
Inflamm. 2011; 8: 22. https://doi.org/10.1186/1476-9255-8-22 
PMid:21871091 PMCid:PMC3175149 
 
24. Anna Bonanno, Sebastiano G. Stefania La G. at al. 25-
Hydroxyvitamin D, IL-31, and IL-33 in Children with Allergic 
Disease of the Airways Mediators Inflamm. 2014; 2014: ID 520241 
 
25. Benson AA, Toh JA, Vernon N, Jariwala SP. The role of 
vitamin D in the immunopathogenesis of allergic skin diseases. 
Allergy. 2012;67(3):296–301. https://doi.org/10.1111/j.1398-
9995.2011.02755.x PMid:22171613  
 
26. Annesi-Maesano I. Perinatal events, vitamin D, and the 
development of allergy. Pediatric Research. 2002;52(1):3–5. 
https://doi.org/10.1203/01.PDR.0000017228.29635.EF 
 
27. Meyts I, Hellings PW, Hens G, et al. IL-12 contributes to 
allergen-induced airway inflammation in experimental asthma. 
Journal of Immunology. 2006;177(9):6460–6470. 
https://doi.org/10.4049/jimmunol.177.9.6460 
 
28. Matheu V, Bäck O, Mondoc E, Issazadeh-Navikas S. Dual 
effects of vitamin D-induced alteration of TH1/TH2 cytokine 
expression: enhancing IgE production and decreasing airway 
eosinophilia in murine allergic airway disease. The Journal of 
Allergy and Clinical Immunology. 2003;112(3):585–592. 
https://doi.org/10.1016/S0091-6749(03)01855-4 
 
29. Wu AC, Kelan T, Lingling L, et al. The effect of vitamin D and 
inhaled corticosteroid treatment on lung function in children. Am J 
Respir Crit. Care Med. 2012; 186(6):508-513. 
https://doi.org/10.1164/rccm.201202-0351OC PMid:22798322 
PMCid:PMC3480528 
 
30. Hala Mohamed ShS, Amany RE, Eman N. Vitamin D and 
markers of airway inflammation in asthma. Egyptian Journal of 
Chest Diseases and Tuberculosis. 2015; 64:779–783. 
https://doi.org/10.1016/j.ejcdt.2015.03.027 
 
31. Clinical Pulmonary Function Testing, Exercise Testing, and 
Disability Evaluation. In Chest Medicine: Essentials Of Pulmonary 
And Critical Care Medicine. 5th edition. Editors: George RB, Light 
RW, Matthay RA, Matthay MA, May 2005. 
 
32. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of 
spirometry. Eur Respir J. 2005;26:319-338. 
https://doi.org/10.1183/09031936.05.00034805 PMid:16055882  
 
33. National Asthma Education, Prevention Program (National 
Heart, Lung, Blood Institute). Second Expert Panel on the 
Management of Asthma. Expert panel report 2: Guidelines for the 
diagnosis and management of asthma. DIANE Publishing; 1998. 
 
34. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk 
PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP. 
International ERS/ATS guidelines on definition, evaluation and 
treatment of severe asthma. European Respiratory Journal. 
2013:erj02020-2013. 
 
35. Sandhu MS, Casale TB. The role of vitamin D in asthma. Ann 
Allergy Asthma Immunol. 2010; 105:191-199. 
https://doi.org/10.1016/j.anai.2010.01.013 PMid:20800785  
 
36. Stephanie K, Hübner M, Matthias J, Maria B, Roland B. 
Severe and uncontrolled adult asthma is associated with vitamin D 
insufficiency and deficiency, Respir Res. 2013; 14:25. 
https://doi.org/10.1186/1465-9921-14-25 PMid:23432854 
PMCid:PMC3648461 
 
37. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, 
Dawson-Hughes B. Estimation of optimal serum concentrations of 
25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 
2006;84:18-28. PMid:16825677  
 
38. Felicia Montero-Arias,Giovanni Sedó-Mejía, Allan Ramos-
Esquivel. Vitamin D Insufficiency and Asthma Severity in Adults 
From Costa Rica. Allergy Asthma Immunol Res. 2013;5(5):283-
288. https://doi.org/10.4168/aair.2013.5.5.283 PMid:24003384 
PMCid:PMC3756174 
 
39. Matheu V, Bäck O, Mondoc E, Issazadeh-Navikas S. Dual 
effects of vitamin D-induced alteration of TH1/TH2 cytokine 
expression: enhancing IgE production and decreasing airway 
eosinophilia in murine allergic airway disease. J Allergy Clin 
Immunol 2003;112:585-92. https://doi.org/10.1016/S0091-
6749(03)01855-4 
 
40. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung 
DY. Vitamin D levels, lung function, and steroid response in adult 
asthma. Am J Respir Crit Care Med. 2010;181:699-704. 
https://doi.org/10.1164/rccm.200911-1710OC PMid:20075384 
PMCid:PMC2868500 
 
41. Lange NE, Litonjua A, Hawrylowicz CM, Weiss S. Vitamin D, 
the immune system and asthma. Expert Rev Clin Immunol. 
2009;5:693-702. https://doi.org/10.1586/eci.09.53 PMid:20161622 
PMCid:PMC2812815 
 
42. Larose TL, Arnulf L, Yue Chen, et al. Serum 25-hydroxyvitamin 
D levels and lung function in adults with asthma: the HUNT Study. 
Eur Respir J. 2015;45(4):1019-26. 
https://doi.org/10.1183/09031936.00069714 PMid:25395037  
 
43. Laura T, Edita G, Simona L, et al. Evaluation of vitamin D 
levels in allergic and non-allergic asthma. Medicine. 2015; 
51(6):321-327. https://doi.org/10.1016/j.medici.2015.11.003 
PMid:26739673  
 
44. Lin Z, Li W. The roles of vitamin D and its analogues in 
inflammatory diseases. Current topics in medicinal chemistry. 
2016;16(11):1242-61. 
https://doi.org/10.2174/1568026615666150915111557 
PMid:26369816  
 
45. Li YM, Cheng XM. Clinical significance of IL-18 and IL-33 
levels changes in the treatment of bronchial asthma with acute 
attack stage by glucocorticoids. Practical Pharmacy and Clinical 
Remedies. 2013; 16: 897-9. 
 
46. Azazi EA, Elshora AE, Tantawy EA, Elsayd MA. Serum levels 
of Interleukin-33 and its soluble receptor ST2 in asthmatic 
patients. Egyptian Journal of Chest Diseases and Tuberculosis. 
2014;63(2):279-84. https://doi.org/10.1016/j.ejcdt.2013.11.005 
 
47. Liu SP, Ma R, Li XA. The relationship between interleukin 33 
promotes and lung inflammation in asthmatic children. Chin J Diffic 
and Compl Cas. 2013; 12:422-4. 
 
48. Préfontaine D, Nadigel J, Chouiali F, et al. Increased IL-33 
expression by epithelial cells in bronchial asthma. J Allergy Clin 
Immunol. 2010; 125: 752-4. 
https://doi.org/10.1016/j.jaci.2009.12.935 PMid:20153038  
 
49. Préfontaine D. Lajoie-Kadoch S, Foley Set al. Increased 
expression of IL-33 in severe asthma: evidence of expression by 
airway smooth muscle cells. J Immunol. 2009; 183: 5094-103. 
https://doi.org/10.4049/jimmunol.0802387 PMid:19801525  
 
50. Liao XM. Changes of plasma interleukin 33 in asthmatic 
patients and its clinical significance. Journal of Clinical Pulmonary 
Medicine. 2014; 19: 33-5. 
 
 
